| Product Code: ETC11272389 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China In-Vitro Diagnostics for Cardiology and Neurology Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, 2021 & 2031F |
3.3 China In-Vitro Diagnostics for Cardiology and Neurology Market - Industry Life Cycle |
3.4 China In-Vitro Diagnostics for Cardiology and Neurology Market - Porter's Five Forces |
3.5 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.7 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China In-Vitro Diagnostics for Cardiology and Neurology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular and neurological diseases in China |
4.2.2 Technological advancements in in-vitro diagnostics for cardiology and neurology |
4.2.3 Growing healthcare expenditure and investment in healthcare infrastructure in China |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and commercialization of diagnostic products |
4.3.2 Limited reimbursement policies for in-vitro diagnostic tests in China |
5 China In-Vitro Diagnostics for Cardiology and Neurology Market Trends |
6 China In-Vitro Diagnostics for Cardiology and Neurology Market, By Types |
6.1 China In-Vitro Diagnostics for Cardiology and Neurology Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Cardiac Biomarkers, 2021 - 2031F |
6.1.4 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Neurological Biomarkers, 2021 - 2031F |
6.1.5 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Genetic Markers, 2021 - 2031F |
6.1.6 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 China In-Vitro Diagnostics for Cardiology and Neurology Market, By Biomarker Type |
6.2.1 Overview and Analysis |
6.2.2 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Troponin, 2021 - 2031F |
6.2.3 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Amyloid Beta, 2021 - 2031F |
6.2.4 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By APOE Testing, 2021 - 2031F |
6.3 China In-Vitro Diagnostics for Cardiology and Neurology Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Heart Attack Detection, 2021 - 2031F |
6.3.3 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Alzheimer's Diagnosis, 2021 - 2031F |
6.3.4 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Stroke Risk Assessment, 2021 - 2031F |
6.3.5 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Neurodegenerative Disorders, 2021 - 2031F |
6.4 China In-Vitro Diagnostics for Cardiology and Neurology Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Diagnostic Labs, 2021 - 2031F |
6.4.4 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Research Centers, 2021 - 2031F |
6.4.5 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Clinics, 2021 - 2031F |
7 China In-Vitro Diagnostics for Cardiology and Neurology Market Import-Export Trade Statistics |
7.1 China In-Vitro Diagnostics for Cardiology and Neurology Market Export to Major Countries |
7.2 China In-Vitro Diagnostics for Cardiology and Neurology Market Imports from Major Countries |
8 China In-Vitro Diagnostics for Cardiology and Neurology Market Key Performance Indicators |
8.1 Adoption rate of in-vitro diagnostic tests for cardiology and neurology in China |
8.2 Number of research collaborations and partnerships in the field of in-vitro diagnostics |
8.3 Rate of introduction of innovative diagnostic technologies in the market |
9 China In-Vitro Diagnostics for Cardiology and Neurology Market - Opportunity Assessment |
9.1 China In-Vitro Diagnostics for Cardiology and Neurology Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China In-Vitro Diagnostics for Cardiology and Neurology Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.3 China In-Vitro Diagnostics for Cardiology and Neurology Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 China In-Vitro Diagnostics for Cardiology and Neurology Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China In-Vitro Diagnostics for Cardiology and Neurology Market - Competitive Landscape |
10.1 China In-Vitro Diagnostics for Cardiology and Neurology Market Revenue Share, By Companies, 2024 |
10.2 China In-Vitro Diagnostics for Cardiology and Neurology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here